WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it will begin offering access to Novo Nordisk’s now available Ozempic ® ...

WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...

A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and ...

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced that eligible Weight Watchers ...